Antibodies
| AbD Serotec | ||
The HuCAL® GOLD antibody library contains more than 15 billion antibody specificities. |
Highly variable CDRs are combined with seven heavy chain and seven light chain variable region genes to create more than 15 billion antibody specificities. |
CysDisplay™ allows specific elution of antibody-displaying phage binding to immobilized antigens through the disruption of a disulphide bridge between phage and antibody. This ensures that all specific binders are eluted, independent of their binding affinity to the antigen. |
Immunohistochemistry analysis of human pancreatic tissue stained with a HuCAL mini-antibody specific for cytokeratin 8. Shown is a lymph follicle with a CK8 positive pancreatic ductus. Courtesy of Prof. H. Merz, Institute for Pathology, University of Lübeck. |
||
| Antibodies Incorporated | ||
AI has developed a 40-acre facility comprised of laboratories, manufacturing and animal care units. |
Through its long history in the industry, AI has established a sterling reputation as a high quality, rapid response producer of antibodies. |
Antibodies Incorporated is looking for collaborators in the European pharmaceutical and biotechnology industries. |
| AntiProt | ||
AntiProt is located within Business Enterprise Company IZB mbH, the leading biotech campus in Europe. |
AntiProt produces antibodies against higher plant, cynobacterial and green algae proteins. |
We produce antibodies from different antigens including proteins from polyacrylamide gels. |
| Biologo | ||
CML (N-epsilon-Carboxymethyl-Lysine) |
Paraffin section of skin stained with anti-S-100 monoclonal antibody and Universal Staining Kit DAB, counter staining Haematoxylin. |
Paraffin section of prostate carcinoma stained with P504S rabbit monoclonal antibody clone 13H4 (courtesy of Dr. P. Chu ZETA Corp.) |
Human skin stained with rabbit anti-human collagen type IV (CO20411). |
Mouse skin stained with rabbit anti-mouse collagen type IV (CO20451). |
|
| Neuromics | ||
IHC result using P2X3 antibody. |
The results of gene expression knockdown using Neuromics' i-Fect kit to delivery siRNA to the CNS in vivo. |
Primary culture from micro-dissected hippocampus and a triple-labeled image for Neurofilament H (red), GFAP(green) and DAPI (blue). |
| Proteogenix | ||
Proteogenix offers protein production and purification, custom antibody production, gene synthesis and peptide synthesis services. |
Custom monoclonal and polyclonal antibody production, conjugation, purification and fragmentation are some of the main activities of Proteogenix. |
Custom recombinant protein production and purification in prokaryotic systems (E coli bacteria) and eukaryotic systems (K lactis yeast) is provided by Proteogenix. |
Proteogenix can provide custom gene synthesis of double-stranded DNA, with a free codon optimisation option. |
Custom peptide synthesis of small and large size, with many modifications (such as acetylation, phosphorylation and KLH conjugation) is also available for polyclonal or monoclonal antibody development. |
|
| Strategic Diagnostics | ||
SDI’s AALAC accredited facility in Windham, Maine, which houses the 60,000 animals used for antibody production. |
Genomic Antibody Technology™ delivers custom antibodies to any protein target for which the DNA or protein sequence is known. |
Genomic Antibody Technology™ is Strategic Diagnostics’ proprietary antigen-free antibody production technique. |
The SEQer™ oncology-focused portfolio, produced with Genomic Antibody Technology™, is comprised of antibody tools that target proteins associated in cancer pathogenesis and progression. |
||
| Synthetic Biomolecules | ||
Through the use of state-of-the-art instrumentation and techniques, Synthetic Biomolecules can provide peptides with lengths ranging from 2 to 100 amino acids, in quantities from milligrams to grams. |
Sets of crude peptides, in 1mg quantities, synthesized and delivered in a 96-well format, are also available for high throughput screening. |
Synthetic Biomolecules also serves as a contract product development company, assisting biotechnology and pharmaceutical companies with development projects. |
